How the war on drugs fueled the fentanyl crisis
The campaign to cut off heroin supplies has encouraged the growth of labs producing the opioid. We need to instead embrace a public health approach
Tuesday, August 29, 2017
A staggering 59,000 people died of drug overdose in 2016 according to a recent New York Times analysis. Annual overdose deaths in the US have already surpassed those inflicted by Aids at its peak. Sparked by big pharma’s criminal mismarketing of opioid painkillers, the overdose epidemic rages to new heights with the increasing street presence of illicitly manufactured fentanyl, a fully synthetic opioid 100 times more potent than heroin. Without an immediate massive investment in harm reduction and treatment, this toll will only worsen, even if the specter of carfentanil, a synthetic opioid 100 times more powerful than fentanyl, is held at bay. (See also: Fentanyl drives rise in opioid-linked deaths in U.S.)